About this trial
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.
Eligibility criteria
Qualifiers
18 years and older
Willing and able to comply with all aspects of the protocol
Disqualifiers
History of allogenic bone marrow transplant
History of allogenic stem cell transplant
Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
Trial design
Treatments tested in this trial
- Exome sequencing
Treatment groups
Sponsors and collaborators
Helix, Inc
Lead sponsor
Medical University of South Carolina
Collaborator
HealthPartners Institute
Collaborator
Memorial Hermann Health System
Collaborator
WellSpan Health
Collaborator
St. Luke's Hospital and Health Network, Pennsylvania
Collaborator
Sanford Health
Collaborator
Renown Health
Collaborator
WakeMed Health and Hospitals
Collaborator
University of Nebraska
Collaborator
Ohio State University
Collaborator
Cone Health
Collaborator
Parkview Health
Collaborator
Rochester Regional Health
Collaborator
University Health Network, Toronto
Collaborator